Chloe presented her work to the Alnylam leadership team.
Chloe served as a Commercial Intern at Alnylam Pharmaceuticals from May 2024 to August 2024. During her internship, she led commercial research for patients participating in IIS (Investigator-Initiated Studies) across the United States and Europe, focusing on patient needs and treatment access.
She played a key role in developing strategies for patient outreach and product label expansion, targeting over five cities. Chloe worked closely with the Vice President of Marketing, participating in weekly strategy meetings and gaining insight into high-level decision-making processes.
In her final presentation, Chloe demonstrated her ability to weave storytelling into data-driven insights, effectively communicating patient research findings and market evaluations to senior leadership. This experience deepened her understanding of patient-centric commercial strategies and honed her skills in strategic planning and professional storytelling.
Alnylam's Intern Class of 2024
